Beyond classic “allergic”/atopic comorbidities, atopic dermatitis (AD) emerges as systemic
disease with increased cardiovascular risk. To better define serum inflammatory and …

Background Moderate-to-severe atopic dermatitis (AD) is increasingly recognized as a
systemic disease, largely due to proteomic blood studies. There are growing efforts to …

Background Atopic dermatitis (AD) is associated with increased systemic inflammation and
cardiovascular risk. Although previous studies have found increased inflammatory proteins …

Background The incidence of adult‐onset atopic dermatitis (AOAD) is increasing. However,
the unique characteristics of AOAD compared to pediatric‐onset AD persisting into …

Background Patients with atopic dermatitis (AD) have systemic biomarker dysregulation that
differs by age group; however, the proteomic characteristics of these age-based changes …

Epidemiological studies suggested an association between atopic dermatitis (AD) and
cardiovascular disease. Therefore, we investigate associations and potential underlying …

Background Molecular studies in atopic dermatitis (AD) are largely restricted to patients with
moderate-to-severe disease. Objective Our aim was to evaluate skin and blood …

Atopic dermatitis (AD) is a chronic, recurrent inflammatory skin disease with a wide range of
heterogeneity. Accurate biomarkers or predictors are the keys to instructing personalized …

Background Atopic dermatitis (AD) is a complex, chronic, inflammatory skin disease with a
diverse clinical presentation. However, it is unclear whether this diversity exists at a …

Background Despite increasing evidence that adults with long-standing atopic dermatitis
(AD) have systemic inflammation, little is known about systemic inflammation in recent-onset …